Answers are grounded in this paper and cite their sources.
Cutaneous pseudolymphoma refers to a group of benign reactive T- or B-cell lymphoproliferative processes that occur in response to identifiable stimuli or without an identifiable etiology. In this article, we report a case of facial cutaneous B-cell pseudolymphoma (CBPL) in Fitzpatrick type V skin that was unresponsive to treatment with high potency topical steroids, intralesional triamcinolone, hydroxychloroquine, and doxycycline but was successfully treated with dupilumab.1
No takes yet. Share an insight, caveat, or question.
Lum et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: